Skip to main content
logo
CNBX Pharmaceuticals Inc. (CNBX)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
At close: Nov 5, 2026

CNBX Pharmaceuticals Financials Overview

Millions USD. Fiscal year is Sep - Aug.

Revenue & Profits
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMay '26 Aug '25 Aug '24 Aug '23 Aug '22 Aug '21
Revenue
--0.130.410.03-
Revenue Growth
---68.29%1269.13%--
Gross Profit
--0.130.410.03-
Operating Income
-0.43-0.27-0.58-0.93-2.95-2.6
Net Income
-0.46-0.31-0.7-3.71-3.72-3.19
Earnings Per Share
-0.00-0.00-0.02-0.42-3.05-2.77
EPS Growth
------

Cash & Debt
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMay '26 Aug '25 Aug '24 Aug '23 Aug '22 Aug '21
Cash & Investments
0.010.020.030.130.121.39
Total Debt
1.171.21.31.341.760.87
Net Cash (Debt)
-1.16-1.18-1.27-1.21-1.640.51
Net Cash Growth
------33.83%
Net Cash Per Share
-0.00-0.01-0.04-0.14-1.340.45

Cash Flow & CapEx
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMay '26 Aug '25 Aug '24 Aug '23 Aug '22 Aug '21
Operating Cash Flow
-0.15-0.17-0.24-0.11-1.68-2.49
Capital Expenditures
---0--0-0
Free Cash Flow
-0.15-0.17-0.25-0.11-1.68-2.49
Free Cash Flow Growth
------

Margins
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMay '26 Aug '25 Aug '24 Aug '23 Aug '22 Aug '21
Gross Margin
--100.00%100.00%100.00%-
Operating Margin
---448.31%-227.07%-9860.37%-
Pretax Margin
---534.46%-904.57%-12428.23%-
Profit Margin
---534.46%-904.57%-12428.23%-
FCF Margin
---188.71%-27.43%-5610.68%-

Valuation
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Aug '25 Aug '24 Aug '23 Aug '22 Aug '21
PS Ratio
--1.480.86142.76-